Catalyst Wire Dossier Catalyst Wire Dossier

RALOXIFENE HYDROCHLORIDE

RALOXIFENE HYDROCHLORIDE · Teva Pharmaceuticals USA, Inc.
Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for RALOXIFENE HYDROCHLORIDE, covering 2008-05-01 to 2024-08-27. Get the full timeline:

Most recent: FDA Approved: RALOXIFENE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

See pricing